Purpose: Familial cortical myoclonic tremor with epilepsy (FCMTE) is an epileptic syndrome with autosomal dominant inheritance, of which four genetic subtypes (FCMTE1-4) have been reported. In the present study, we described the clinical and neurophysiologic features of a newly diagnosed Chinese FCMTE family, and investigated the genetic cause for this disease. Methods: Clinical information was obtained from affected and normal individuals of an FCMTE family comprising 41 members. Electroencephalographies were analyzed in five of six affected members (including the proband). Brain magnetic resonance imaging, somatosensory evoked potential with Creflex analysis and magnetoencephalography was performed in the proband. Genomic DNA of three affected and two unaffected individuals was analyzed to detect the genetic mutations by using wholeexome sequencing. Results: The inheritance pattern of the pedigree was autosomal dominant. A novel missense mutation c.475C > T (p.Ala159Thr) of PLA2G6 were identified in this family. The mutated locus is highly conserved among other species. The mutation is predicted to have a functional impact, and completely cosegregated with the phenotype. Conclusion: This study identifies a novel PLA2G6 mutation that is the possible genetic cause of FCMTE in this family. This mutation and associated clinical features expand the spectrum and phenotypes of PLA2G6-related disorders including neurodegenerative diseases.
Introduction
Familial cortical myoclonic tremor with epilepsy (FCMTE) is an autosomal dominant epileptic syndrome, characterized by adultonset cortical myoclonic tremors of the extremities, infrequent epileptic seizures, and a benign nonprogressive course without cerebellar ataxia or dementia [1] . The diagnosis of FCMTE is based on clinical and electrophysiological criteria, including enhanced cortical reflex at rest, giant cortical somatosensory evoked potentials (SEPs) and premyoclonus cortical spikes detected by the jerk-locked back averaging method [1, 2] . Previously, such phenotypes were reported in multiple disorders, including benign adult familial myoclonic epilepsy (BAFME) [1] , autosomal dominant cortical myoclonus and epilepsy (ADCME) [3] , and familial adult myoclonic epilepsy (FAME) [4] .
Genetic studies have linked FCMTE to four chromosomal loci: FCMTE1 (8q23.3-q24.11) [1] , FCMTE2 (2p11.1-q12.1) [3] [4] [5] , FCMTE3 (5p15.31-p15.1) [6] , and FCMTE4 (3q26.32-3q28) [7] . Additionally, a mutation in the aminocarboxymuconate semialdehyde decarboxylase (ACMSD) gene was identified in a large Spanish family with cortical myoclonus, epilepsy and parkinsonism by whole-exome sequencing [8] . Moreover, a novel in-frame insertion/deletion (indels) were identified in the a2-adrenergic receptor subtype B (ADRA2B) gene in two Italian families [9] . To date, two studies involving Chinese families with FCMTE have been reported: one excluded the linkage to FCMTE1 and FCMTE2 [10] , and another mapped an FCMTE pedigree to 5p15.31-p15.1, the FCMTE3 locus [11] .
In this study, we report a novel causative mutation identified by whole-exome sequencing in the gene coding for phospholipase A2, group VI (PLA2G6), which co-segregates with a large newly diagnosed Chinese FCMTE pedigree.
Methods

Subjects
The new Chinese FCMTE family (Fig. 1A) comprises 41 members. A pedigree map was constructed based on the clinical information on all affected and unaffected members and their spouses. The inheritance of the FCMTE family was consistent with an autosomal dominant pattern, affecting eight individuals across three generations. All of the six available affected and four unaffected individuals underwent thorough neurological evaluation by two senior neurologists. Electroencephalography (EEG) was performed for five affected members,and brain magnetic resonance imaging (MRI), SEPs, C-reflex analysis, as well as magnetoencephalography (MEG) was performed for the proband (II:16), as indicated with arrow in Fig. 1A . 
Sample preparation
Next-generation of sequencing and data analysis
Exon-enriched DNA was sequenced using the Illumina HiSeq 2500 platform following the manufacturer's instructions (Illumina Inc., San Diego, CA). Raw image files were processed using bcl2fastq conversion software (Illumina) for base calling and the generation of raw data. Low-quality variations were filtered out using the quality score !20 (Q20). Sequencing reads were aligned to the NCBI human reference genome hg19 using the BurrowsWheeler Aligner (http://bio-bwa.sourceforge.net/). SAMtools (http://samtools.sourceforge.net/) and Pindel (http://gmt.genome.wustl.edu/packages/pindel/) were used to analyze single nucleotide polymorphisms (SNPs) and indels in the sequences.
According to the autosomal dominant inheritance pattern, we hypothesized that the causative mutations in this pedigree to be heterozygous. The identification of disease-causing mutations were conducted by sequential filtering and selection of variants as follows: (i) removal of synonymous changes and SNPs with minor allele frequencies >5% [12] (http://www.ncbi.nlm.nih.gov/projects/SNP); (ii) filtering of nonsynonymous changes that were functionally benign or tolerated as predicted by the SIFT (http://sift.jcvi.org) and PolyPhen2 softwares (http://genetics.bwh.harvard.edu/pph2) [13, 14] ; (iii) selection of all heterozygous variants identified in affected members and removal of those found in unaffected members; (iv) analysis of the function of mutated genes and their relationship with FCMTE; (v) Sanger sequencing of samples collected from other family members to validate prioritized variations.
Results
Clinical data
All six affected members (II:4, II:6, II:8, II:10, II:16, and III:7) presented with cortical myoclonic tremors, while five had The proband (II:16) in our study is a 43-year-old woman. At 28 years of age, she suffered from tremors in both hands. Initially, the tremors were confined to fingers and hands, and were mainly provoked by action and posture. The myoclonus then extended to both the upper and lower extremities, and occasionally to head, eyelids or trunk. The tremor/myoclonus also occurred at rest but disappeared during sleep. The tremor on the left limbs was more severe than the right ones. She has experienced generalized tonicclonic seizures since the age of 36, in a frequency of twice per year. Multiple factors were found to worsen the myoclonus and seizures, such as photic stimuli, emotional stress, lack of sleep, tiredness, and alcohol consumption. She complained of memory impairment but no deficit was revealed by cognition assessment using the Mini Mental State Evaluation [15] . After standard treatment with valproic acid she became seizure-free. Four other affected individuals (II:4, II:6, II:8, and II:10) in this family showed similar symptoms. However, patient III:7 only suffered from tremors in both hands and has not received drug treatment (Table 1) .
Neurophysiological data
Five affected family members underwent EEG. EEG background activity was normal in two affected members, a slightly slower frequency (7.5-9 Hz) was observed in three affected members, and frequent diffuse 4-7 Hz spike/polyspike-wave discharges occurred in all affected members. And photomyoclonus was induced by photic stimulation in two affected members. Increased median nerve amplitudes of the cortical SEPs and the C-reflex were observed in the proband. A brain MRI of the proband appeared normal, while a MEG recording revealed clusters of dipole sources localizing in the right frontal lobe and close to the motor area. This location could be the origin of myoclonus and epilepsy (Fig. 1B) .
Genetic data
An average of 2.24 Gb of high-quality sequence was generated per individual, with 96.5% of the total bases mapped to the reference genome with a mean coverage of 30Â. An average total of 20,939 genetic variations were identified per subject, including nonsynonymous mutations, splice-acceptor/donor site variations and indels (Table 2) . After comprehensive analysis, we identified three candidate genes, each containing a suspicious variant. Sanger sequencing of all the ten members showed that the variants in the dual specificity phosphatase 27 gene (DUSP27; c.1702G > A) did not segregate with the disease in the remaining family members. We then focused on the two candidate variants: a missense mutation at 22q13.1 in PLA2G6 [c.475C > T (p.Ala159Thr)], and a mutation in SNRNP200 [c.*100C > T (m.6643G > A)] in the untranslated region after the termination codon 100 (Fig. 1C) .
The two variants of the different genes were confirmed to be in complete co-segregation with this family. Additionally, neither of the mutations was detected in 1,000 unaffected control individuals of matched Chinese ancestry who were also examined using Sanger sequencing, suggesting that they are not polymorphisms.
The mutated region of the PLA2G6 locus (c.475C > T) segregated in a dominant manner in this family (Fig. 1D) , and was found to be highly conserved among species (Fig. 1E ). PolyPhen2 analysis suggested that the mutation is likely to be damaging, with HumDiv and HumVar scores of 1.000 and 0.998, respectively.
The mutation at the SNRNP200 gene in the present study is within the untranslated region (c.*100C > T), and the corresponding functional change is currently unclear.
Discussion
FCMTE is an autosomal dominant epileptic syndrome, of which four clinical and genetic subtypes have been reported previously. FCMTE1 is the classical type that presents with finger myoclonus, infrequent seizures, photosensitivity and an absence of mental deficiency [1] . FCMTE2 manifests with myoclonus, infrequent seizures, atypical phenotype of complex partial seizures, intractable seizures and mental retardation [3] [4] [5] . FCMTE3 [6] and FCMTE4 [7] have only been reported in one family each. Some patients of both families showed seizures before the onset of tremors, while complex partial seizures with visual hallucinations have also been documented in FCMTE3. The clinical manifestations of the current Chinese FCMTE pedigree were characterized by cortical myoclonus, infrequent seizures and hand tremors before the onset of seizures, and no complex partial seizures or mental deficiency were noted. These features are close to FCMTE1, and different from the three other subtypes.
Our whole-exome sequencing study identified two possible mutations co-segregating with the current pedigree, namely the SNRNP200 c.*100C > T (m.6643G > A) and PLA2G6 c.475C > T (p. Ala159Thr) mutations. However, the SNRNP200 mutation does not reside in the coding region. Moreover, brr2, the protein encoded by SNRNP200 is mainly expressed in cardiac and skeletal muscle and only only weakly expressed in the brain. SNRNP200 mutations usually result in autosomal dominant retinitis pigmentosa [16, 17] . Although SNRNP200 locates within the FCMTE2 locus (2p11.1-q12.1), there has been no evidence supporting an association of the SNRNP200 mutations with epilepsy. Therefore, it is not likely to be the causative gene for this FCMTE family.
In contrast, the c.475C > T mutation in PLA2G6 is very likely causative for the disease. First, the mutated site in ankyrin repeat is highly conserved among multiple species and the mutation is predicted to be damaging. Second, PLA2G6 mutations are causative for a heterogeneous group of neurodegenerative diseases, including infantile neuroaxonal dystrophy (INAD), idiopathic neurodegeneration with brain iron accumulation including Karak syndrome and early-onset dystonia parkinsonism [18] [19] [20] [21] [22] , whose brain pathology and imaging features are usually similar to FCMTE [23, 24] .
PLA2G6 is located on chromosome 22q and encodes the iPLA2-VIA protein (PLA2), one of the several calcium-independent phosphatases that catalyzes the hydrolysis of sn-2 position phospholipids [25] . PLA2 is considered the first rate-limiting enzyme in the generation of downstream products of arachidonic acid [26] . and play an important role in phospholipid remodeling, arachidonic acid release, leukotriene and prostaglandin synthesis, and cell apoptosis [27] . The abnormal metabolism of arachidonic acid has been associated with increased neuronal excitability and seizure propagation [28] .
Arachidonic acid increases the release of glutamate from synaptosomes [29, 30] , inhibits glutamate uptake into neurons [31, 32] , and activates N-methyl-D-aspartate (NMDA) receptors [33] . Sustained activation of NMDA receptors by quinolinic acid increases the synaptosomal release of the excitatory neurotransmitter glutamate, and decreases glutamate uptake by astrocytes in culture and in hippocampal slices [34] . NMDA receptor activation also increases glutamate uptake into synaptic vesicles [35] , which may contribute to the increased glutamate levels in the synaptic cleft and subsequent excitotoxicity [36] . In addition, arachidonic acid metabolism abnormality causes a reduction in the levels of cyclooxygenase-2 (COX-2) protein, deletion of which increases the susceptibility to glutamate-related excitotoxicity or seizures [37, 38] .
Taken together, we reported a novel mutation in PLA2G6 gene in a Chinese FCMTE family. The mutation may cause abnormality in arachidonic acid metabolism, which, in turn, increases the glutamate level and lead to myoclonus and seizures. This mutation and associated clinical features expand the spectrum and phenotypes of PLA2G6-related disorders including neurodegenerative diseases.
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